Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 5 (2008), Issue 1 (January)

1. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value.
   Autoimmunity, 41(1): 111-5. [Abstract] [Full-text]
2. Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-up.
   Autoimmunity, 41(1): 87-91. [Abstract] [Full-text]
3. Could preoperative preferences and expectations influence surgical decision making? Rheumatoid arthritis patients contemplating metacarpophalangeal joint arthroplasty.
   Plast Reconstr Surg, 121(1): 175-80. [Abstract] [Full-text]
4. Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis.
   Ann Rheum Dis, 67(2): 270-2. [Abstract] [Full-text]
5. Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the disease activity score.
   Ann Rheum Dis, 67(2): 266-9. [Abstract] [Full-text]
6. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis.
   Ann Rheum Dis, 67(2): 260-5. [Abstract] [Full-text]
7. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
   Ann Rheum Dis, 67(2): 182-8. [Abstract] [Full-text]
8. The importance of B-cells and ecto-5'nucleotidase in Mycoplasma fermentans infection and the relevance to rheumatoid arthritis.
   Immunology, 123(2): 187-96. [Abstract] [Full-text]
9. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis.
   Ann Rheum Dis, 67(2): 189-94. [Abstract] [Full-text]
10. Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results.
    Ann Rheum Dis, 67(2): 238-43. [Abstract] [Full-text]
11. Subintimal Ki-67 as a synovial tissue biomarker for inflammatory arthropathies.
    Ann Rheum Dis, 67(2): 162-7. [Abstract] [Full-text]
12. Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis.
    Ann Rheum Dis, 67(2): 248-50. [Abstract] [Full-text]
13. Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis.
    Ann Rheum Dis, 67(2): 256-9. [Abstract] [Full-text]
14. Characteristics and survival of 26 patients with paraneoplastic arthritis.
    Ann Rheum Dis, 67(2): 244-7. [Abstract] [Full-text]
15. Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk.
    Ann Rheum Dis, 67(2): 229-32. [Abstract] [Full-text]
16. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
    Ann Rheum Dis, 67(2): 212-7. [Abstract] [Full-text]
17. Haplotypes of PADI4 susceptible to rheumatoid arthritis are also associated with ulcerative colitis in the Japanese population.
    Clin Immunol, 126(2): 165-71. [Abstract] [Full-text]
18. TNFalpha blockade in human diseases: mechanisms and future directions.
    Clin Immunol, 126(2): 121-36. [Abstract] [Full-text]
19. Antigen-specific therapy of rheumatoid arthritis.
    Expert Opin Biol Ther, 8(2): 191-9. [Abstract] [Full-text]
20. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
    Scand J Immunol, 67(2): 185-92. [Abstract] [Full-text]
21. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial.
    Lancet, 371(9608): 205-14. [Abstract] [Full-text]
22. Adult-onset Still's disease presenting as fever of unknown origin in a patient with HIV infection.
    Clin Infect Dis, 46(4): e41-3. [Abstract] [Full-text]
23. Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs.
    Expert Opin Ther Targets, 12(2): 171-83. [Abstract] [Full-text]
24. Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel.
    Rheumatology (Oxford), 47(2): 194-9. [Abstract] [Full-text]
25. Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective.
    Rheumatology (Oxford), 47(2): 188-93. [Abstract] [Full-text]
26. Discrepancies between the EULAR response criteria and the NICE guidelines for continuation of anti-TNF therapy in RA: a cause for concern?
    Rheumatology (Oxford), 47(2): 180-2. [Abstract] [Full-text]
27. Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis.
    Rheumatology (Oxford), 47(2): 138-41. [Abstract] [Full-text]
28. New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment.
    Rheumatology (Oxford), 47(2): 121-5. [Abstract] [Full-text]
29. Involvement of thioredoxin reductase 1 in the regulation of redox balance and viability of rheumatoid synovial cells.
    Biochem Biophys Res Commun, 367(2): 491-6. [Abstract] [Full-text]
30. Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis?
    Mol Pharmacol, 73(2): 587-600. [Abstract] [Full-text]
31. Calorimetry outside the box: a new window into the plasma proteome.
    Biophys J, 94(4): 1377-83. [Abstract] [Full-text]
32. Progressive preclinical interstitial lung disease in rheumatoid arthritis.
    Arch Intern Med, 168(2): 159-66. [Abstract] [Full-text]
33. Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.
    Nat Clin Pract Rheumatol, 4(2): 98-105. [Abstract] [Full-text]
34. Synoviolin, protein folding and the maintenance of joint homeostasis.
    Nat Clin Pract Rheumatol, 4(2): 91-7. [Abstract] [Full-text]
35. Corneal involvement in rheumatoid arthritis: an in vivo confocal study.
    Invest Ophthalmol Vis Sci, 49(2): 560-4. [Abstract] [Full-text]

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.